SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017966
Filing Date
2019-05-09
Accepted
2019-05-09 16:06:39
Documents
59
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arpo-10q_20190331.htm 10-Q 1356261
2 EX-31.1 arpo-ex311_8.htm EX-31.1 20429
3 EX-31.2 arpo-ex312_7.htm EX-31.2 21645
4 EX-32.1 arpo-ex321_9.htm EX-32.1 10590
5 EX-32.2 arpo-ex322_6.htm EX-32.2 11794
  Complete submission text file 0001564590-19-017966.txt   4474289

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arpo-20190331.xml EX-101.INS 861004
7 XBRL TAXONOMY EXTENSION SCHEMA arpo-20190331.xsd EX-101.SCH 34200
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arpo-20190331_cal.xml EX-101.CAL 28076
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arpo-20190331_def.xml EX-101.DEF 81105
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arpo-20190331_lab.xml EX-101.LAB 272424
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arpo-20190331_pre.xml EX-101.PRE 205394
Mailing Address 9987 CARVER ROAD CINCINNATI OH 45242
Business Address 9987 CARVER ROAD CINCINNATI OH 45242 (513) 985-1920
Aerpio Pharmaceuticals, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38560 | Film No.: 19810513
SIC: 2834 Pharmaceutical Preparations